During the past decade, Hospital General Universitario de Elche conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 44 clinical trials were completed, i.e. on average, 31.9% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 34 clinical trials were completed. i.e. 53.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Universitario de Elche" #1 sponsor was "Hospital General Universitario Elche" with 13 trials, followed by "Pfizer" with 12 trials sponsored, "Spanish Breast Cancer Research Group" with 11 trials sponsored, "Spanish Lung Cancer Group" with 11 trials sponsored and "Janssen Research & Development, LLC" with 11 trials sponsored. Other sponsors include 136 different institutions and companies that sponsored additional 107 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario de Elche" #1 collaborator was "Eli Lilly and Company" with 6 trials as a collaborator, "Hoffmann-La Roche" with 6 trials as a collaborator, "Instituto de Salud Carlos III" with 5 trials as a collaborator, "Pfizer" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Universitario de Elche" are "Breast Cancer" (9 trials), "Lung Cancer" (6 trials), "Alzheimer's Disease" (5 trials), "COVID-19" (4 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Hospital General Universitario de Elche" in a lesser frequency.

Most popular intervention types in "Hospital General Universitario de Elche" are "Drug" (136 trials), "Other" (18 trials), "Procedure" (17 trials), "Biological" (15 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Capecitabine" (7 trials), "Oxaliplatin" (7 trials), "Leucovorin" (6 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Universitario de Elche" are 176 trials for "All" genders, 13 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General Universitario de Elche". 3 are not yet recruiting, 42 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Hospital General Universitario de Elche, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Universitario de Elche, 3 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 12 trials that are defined as “Not Applicable".